Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia (TIP)

This study has been completed.
Information provided by (Responsible Party):
Marcus Saemann, Medical University of Vienna Identifier:
First received: January 26, 2009
Last updated: August 30, 2012
Last verified: August 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)